VALERIE L. ASBURY

Corporate Board Profile

Tech Score: 0/100

TACTILE SYSTEMS TECHNOLOGY INC

Filing Date	Source Excerpt
2024-03-27	Valerie L. Asbury Independent President and Chief Executive Officer, LifeScan, Inc. Age: 64 Director Since: 2022 Board Committees: Audit Committee/Nominating and Corporate Governance Committee (Chair) 2023 Director Compensation Table Fees Earned or Paid in Cash: $70,000 Stock Awards: $144,991 Total: $214,991
2025-03-28	Ms. Asbury has served as President and Chief Executive Officer of LifeScan, Inc., a diagnostic systems manufacturer with products focusing on the diabetes market, since October 2018. Prior to October 2018, LifeScan was a subsidiary of Johnson & Johnson. Ms. Asbury held various positions at Johnson & Johnson beginning in 1998, serving in various leadership roles of increasing responsibility across five different medical device and pharmaceutical divisions, including 10 years in the diabetes consumer medical device space, where she focused on strategic growth and talent development. Her most recent positions at Johnson & Johnson were Global President, Diabetes Solutions from 2013 to 2018, including the Global LifeScan subsidiary until its sale in October 2018. Ms. Asbury serves as an independent director of the Board to Nixon Medical, a family-owned Medical Apparel and Linen Service Specialist, based in Delaware. She has served on the Nixon Medical Board since 2019 and currently Chairs the President's Evaluation Committee. We believe Ms. Asbury is qualified to serve on our Board of Directors because of her extensive industry and leadership experience.

Filing Date

Source Excerpt

2024-03-27

Valerie L. Asbury Independent President and Chief Executive Officer, LifeScan, Inc. Age: 64 Director Since: 2022 Board Committees: Audit Committee/Nominating and Corporate Governance Committee (Chair) 2023 Director Compensation Table Fees Earned or Paid in Cash: $70,000 Stock Awards: $144,991 Total: $214,991

2025-03-28

Ms. Asbury has served as President and Chief Executive Officer of LifeScan, Inc., a diagnostic systems manufacturer with products focusing on the diabetes market, since October 2018. Prior to October 2018, LifeScan was a subsidiary of Johnson & Johnson. Ms. Asbury held various positions at Johnson & Johnson beginning in 1998, serving in various leadership roles of increasing responsibility across five different medical device and pharmaceutical divisions, including 10 years in the diabetes consumer medical device space, where she focused on strategic growth and talent development. Her most recent positions at Johnson & Johnson were Global President, Diabetes Solutions from 2013 to 2018, including the Global LifeScan subsidiary until its sale in October 2018. Ms. Asbury serves as an independent director of the Board to Nixon Medical, a family-owned Medical Apparel and Linen Service Specialist, based in Delaware. She has served on the Nixon Medical Board since 2019 and currently Chairs the President's Evaluation Committee. We believe Ms. Asbury is qualified to serve on our Board of Directors because of her extensive industry and leadership experience.

Data sourced from SEC filings. Last updated: 2026-03-05